Related Experiment Video
Updated: Apr 15, 2026
04:56
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
1.4K
Microparticles impact coagulation after traumatic brain injury
Emily F Midura1, Peter L Jernigan1, Joshua W Kuethe1
1Division of Research, Department of Surgery and Institute for Military Medicine, University of Cincinnati, Cincinnati, Ohio.
The Journal of Surgical Research
|April 8, 2015
Summary
Microparticles (MPs) generated after traumatic brain injury (TBI) significantly alter coagulation. These MPs may be key drivers of the hypercoagulable state observed in TBI patients, impacting clot formation and function.
Area of Science:
- Neuroscience
- Hematology
- Trauma Research
Background:
- The hypercoagulable state following traumatic brain injury (TBI) is not fully understood.
- Platelet and microparticle (MP) alterations are suspected contributors to TBI-induced coagulopathy.
- The specific roles of platelets and MPs in TBI pathophysiology remain unclear.
Purpose of the Study:
- To investigate the role of microparticles (MPs) in the altered coagulation observed after traumatic brain injury (TBI).
- To determine the functional contribution of MPs to platelet function and clot formation post-TBI.
Main Methods:
- A murine model of moderate TBI was utilized with blood collection at various time points post-injury.
- Nanoparticle Tracking Analysis quantified MP numbers and characteristics.
- Thromboelastometry assessed platelet counts and coagulation parameters.
- MP procoagulant activity was measured to compare injured and sham groups.
Main Results:
- Circulating platelet numbers remained unchanged 24 hours post-TBI, but their contribution to clot formation decreased.
- Total circulating MP numbers declined, yet MP procoagulant activity increased in TBI mice.
- Transferring sham MPs to TBI blood normalized platelet clot contribution, while TBI MPs impaired sham blood clotting.
Conclusions:
- Microparticles (MPs) generated after TBI play a significant role in altered coagulation.
- These TBI-induced MPs are likely crucial in developing the posttraumatic hypercoagulable state in patients.
- Understanding MP function offers potential therapeutic targets for TBI-related coagulopathy.
Related Concept Videos
01:09Coagulation
12.3K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
12.3K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
15.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.8K